Clinical Trials Logo

Renal Stone clinical trials

View clinical trials related to Renal Stone.

Filter by:

NCT ID: NCT04519294 Active, not recruiting - Urolithiasis Clinical Trials

Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE)

Start date: June 16, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to compare the effects, good and/or bad, of a treatment for removing kidney stones called the SURE procedure for stone evacuation to the standard treatment using a basket for stone removal.

NCT ID: NCT04404855 Completed - Kidney Stone Clinical Trials

Antibiotic Selection Using Next Generation Sequencing vs Urine Culture

ACCESS
Start date: December 18, 2019
Phase: N/A
Study type: Interventional

This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.

NCT ID: NCT04346134 Completed - Renal Stone Clinical Trials

Mini- Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy for High Density Renal Stones

Start date: July 14, 2020
Phase: N/A
Study type: Interventional

Several studies were conducted to compare extracorporeal shockwave lithotripsy (SWL) and percutaneous nephrolithotomy (PNL) as treatment options for medium size lower caliceal high dense stones. However, no studies compared these options for non- lower polar stones. In the present study the investigators will compare mini-PNL and SWL in treatment of non- lower polar, medium size, high dense renal stones in reference to the stone free rate and safety of the procedures. Pre-operative evaluation including abdominal non-contrasted computed tomography will be performed for all patients. Patients will be randomly allocated into two equal groups and will be treated by either mini-PNL or SWL. postoperative, patients will be followed by regularly for 3 months. the outcome of the procedures will be evaluated and compared between groups.

NCT ID: NCT04160936 Completed - Renal Stone Clinical Trials

The Efficacy of Peritubal Analgesic Infiltration in Postoperative Pain Following Percutaneous Nephrolithotomy

Start date: February 10, 2018
Phase: N/A
Study type: Interventional

The investigators aim to investigate the effect of peritubal local anesthetic infiltration on pain scores and analgesic consumption in patients who underwent percutaneous nephrolithotomy.

NCT ID: NCT04077359 Completed - Clinical trials for Renal Cell Carcinoma

Prospective Trial for Examining Hematuria Using Computed Tomography

PROTEHCT
Start date: September 15, 2019
Phase: N/A
Study type: Interventional

The primary objective is to evaluate whether one-phase nephrographic CT (experimental) is sufficient to detect urothelial cell carcinoma in patients with hematuria compared to the traditional four-phase CT (control).

NCT ID: NCT04071340 Enrolling by invitation - Renal Stone Clinical Trials

The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones

Start date: September 1, 2019
Phase:
Study type: Observational

- The primary aim is to study the natural history of single-calyx asymptomatic nonobstructing stone disease. - The Secondary aim is to determine the predictors of the need for intervention and of cure in such population.

NCT ID: NCT03939325 Not yet recruiting - Renal Stone Clinical Trials

ESWL on Disintegration of Renal Stones

Start date: May 5, 2019
Phase:
Study type: Observational [Patient Registry]

The impact of different frequencies on pattern of disintegration of renal stones

NCT ID: NCT03828175 Completed - Renal Stone Clinical Trials

Basic Hemodynamic Monitoring Reliability During Percutaneous Nephrolithotomy.

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This prospective pre and post-quasi-descriptive single group interventional study will be done at urology and nephrology center -Mansoura University during the year 2019, for a 3-month duration, starting 1-2-2019 till 1-4-2019 after approval of IRB (Institutional Review Board) code no R/18.03.103 on 5/5/2018, Mansoura Faculty of Medicine. correlating Basic hemodynamics with noninvasive cardiac output for diagnostic reliability during percutaneous nephrolithotomy hidden bleeding under spinal anesthesia

NCT ID: NCT03719456 Completed - Renal Stone Clinical Trials

Prospective Assessment of Procedure-Related and Patient-Reported Outcomes After Retrograde Intrarenal Surgery (RIRS) for Renal Calculi Less Than 20 mm

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The investigators aim at this study to prospectively assess procedure-related outcomes after RIRS for renal calculi less than 20 mm, including stone free rate (SFR), predictors of successful outcome, complications types/rate, readmission rate and the need of auxiliary procedures. In addition, patient-reported outcomes after this modality of intervention are going to be assessed.

NCT ID: NCT03714477 Withdrawn - Hypertension Clinical Trials

A Study to Investigate the Effect of Extracorporeal Shockwave Lithotripsy on Hypertension

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Having the advantages of being minimally invasive and simple, extracorporeal shock wave lithotripsy (SWL) remains one of the treatment options for renal stones less than 2cm. Although SWL is the most minimally invasive surgical approach for stone, there are still some concern about its short and long term side effect. While, there are some evidences that SWL might lead to increase in new onset hypertension, investigator's recent study suggested it might also cause worsening of blood pressure control in patient with known hypertension. Therefore, further studies are needed to confirm the initial finding. This study recruits patients who have hypertension and are currently diagnosed to have renal stone and planned for SWL, in order to to investigate the effect of SWL on blood pressure control. After informed consent and background information have been obtained, patients will be randomized to either have routine SWL (treatment arm) or 6 months later (control arm). Group 1 patients will have blood pressure monitored for one day at home by an handy automated blood pressure measuring machine before SWL and 6 months after SWL. Group 2 patients will have blood pressure monitoring immediately and then 6 months later, just prior to the SWL.